2006
DOI: 10.1158/0008-5472.can-05-3189
|View full text |Cite
|
Sign up to set email alerts
|

SPARC Represses E-Cadherin and Induces Mesenchymal Transition during Melanoma Development

Abstract: During progression of melanoma, loss of the cell-cell adhesion molecule E-cadherin contributes to uncontrolled growth and invasive behavior of transformed melanocytes. Secreted protein acidic and rich in cysteine (SPARC) is a nonstructural matricellular protein that regulates cell-matrix interactions leading to alterations in cell adhesion and proliferation. Overexpression of SPARC has been associated with progression of various cancers, including melanoma; however, its role in primary tumor development is not… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

20
146
3

Year Published

2007
2007
2018
2018

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 145 publications
(169 citation statements)
references
References 46 publications
20
146
3
Order By: Relevance
“…3 d). Thus, the CE adhesions and the CC junctions have an antagonistic relationship, consistent with previous experimental findings of integrincadherin crosstalk (19,30). The reduced stabilization of CEs in softer ECMs caused low protrusion and actomyosin forces, which in turn disabled the dissociation rate of CC junctions.…”
Section: Resultssupporting
confidence: 89%
“…3 d). Thus, the CE adhesions and the CC junctions have an antagonistic relationship, consistent with previous experimental findings of integrincadherin crosstalk (19,30). The reduced stabilization of CEs in softer ECMs caused low protrusion and actomyosin forces, which in turn disabled the dissociation rate of CC junctions.…”
Section: Resultssupporting
confidence: 89%
“…In the tumour microenvironment, both neoplastic and neighbouring stromal cells can produce SPARC, thereby imparting a complexity of action for SPARC in cancer. In melanoma, we and others have previously identified an autocrine role for SPARC in regulating invasiveness, epithelial-mesenchymal-like transition and melanoma survival [14][15][16]42 . Although SPARC expression has been clearly linked to cancer progression through cell-autonomous and non-autonomous actions in cell invasion and survival 20,43,44 , its function as a paracrine factor has remained poorly characterized.…”
Section: Discussionmentioning
confidence: 85%
“…We identify the matricellular SPARC protein, as a critical tumour-secreted permeability factor and a novel paracrine mediator of endothelium permeability during melanoma metastatic dissemination to lungs. Abnormal expression of SPARC has been reported in various cancer cell types including melanoma 13 , in which SPARC was shown to play a key role in melanoma cell tumorigenicity [14][15][16] . However, its role as a paracrine mediator of haematogenous metastasis during extravasation remains unclear.…”
mentioning
confidence: 99%
“…Inflammatory factors present in the TME, including TGF-β and IL-1β, lead to increased invasion and metastasis in melanoma, glioma and NSCLC [95][96][97]. These inflammatory mediators are present early in the TME.…”
Section: Inflammation In the Tme Drives Invasionmentioning
confidence: 99%
“…Expression of SPARC in tumor cells, CAFs and stromal endothelial cells can lead to an EMT-like phenotype, including loss of cell-cell adhesion and induction of MMPs and has been shown to increase tumorigenicity [110][111][112]. Expression of SPARC in the tumor stroma is correlated independently with poor prognosis and increased mortality in NSCLC and pancreatic cancers [113,114] and leads to increased invasion and metastasis in melanoma, glioma and NSCLC [95][96][97]115]. Tumor-associated macrophages recruited to the inflammatory microenvironment also secrete SPARC [116].…”
Section: Inflammation In the Tme Drives Invasionmentioning
confidence: 99%